Haemonetics (NYSE:HAE) today reported 2nd quarter earnings that beat the street on earnings and narrowly missed revenue expectations, with shares slumping slightly in response. Haemonetics reported profits of $12.9 million, or 25¢ per share, on sales of $220 million for the 3 months ended September 26. That amounts to a significant 71.8% bottom line gain on […]
Blood Management
Haemonetics expands in South Carolina
Haemonetics (NYSE:HAE) is planning to spend $20 million on an expansion of a facility in Union, S.C., that will add 40 jobs over the next 5 years. Braintree, Mass.-based Haemonetics, which makes blood management products, plans to add 3,000 square feet to the Union plant, where it’s had a presence for 20 years, and upgrade its […]
Baxter gets in on Harvard spun-out Opsonix
New Harvard spin-out blood pathogen-extracting device developer Opsonix said it raised $8 million in its Series A round upon launching, led by Baxter (NYSE:BAX) Ventures. Opsonix is developing a device to remove infectious pathogens and toxins from circulating blood, to treat blood-borne infectious diseases,including sepsis, the Cambridge, Mass.-based company said. “Opsonix’s pathogen-extracting therapy provides a novel […]
Haemonetics slumps on lowered outlook
A week after revealing the departure of CEO Brian Concannon, Haemonetics (NYSE:HAE) yesterday lowered its outlook for fiscal 2016, saying it expects lower revenues from Russia and Japan and the slow uptake on its HaemoCloud software during the 2nd half of the year. Braintree, Mass.-based Haemonetics, which is slated to release its fiscal 2nd-quarter results Nov. 4, said […]
Neuravi launches EmboTrap in Europe
Neuravi said today it launched its EmboTrap minimally invasive thrombectomy device for the treatment of acute ischemic stroke in Europe. The Embotrap device functions by capturing clots and allowing blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke, CEO Eamon Brady told MassDevice.com in an interview in June. […]
Aethlon Medical extends DARPA contract
Aethlon Medical (OTC:AEMD) said today it extended its contract with DARPA to develop a device to reduce the incidence of sepsis, a commonly fatal infection encountered by combat-injured soldiers. The contract with DARPA was originally inked in September 2011 and has been extended to its 5th year with Aethlon, the company said. The reward is a […]
Velico Medical extends BARDA contract
Velico Medical said yesterday that the U.S. Department of Health & Human Services’ Biomedical Advanced Research and Development Authority extended its contract with Velico to further the development of its spray dried plasma technology. The federal authority exercised an option to extend the contract through March 2017 and up to an additional $15.5 million, approximately, […]
Report: C.R. Bard underrepresented risk of Recovery IVC filter
C.R. Bard (NYSE:BCR) may have downplayed the risk associated with its Recovery blood clot filter, according to a new investigation from NBC News published today. The Recovery inferior vena cava filter device is designed to catch blood clots in the vascular system before they can reach the heart or lungs. The invesigation reports that 27 deaths and […]
Quanta wins UK grant for nocturnal hemodialysis device
Quanta Fluid Solutions said Tuesday it won a $2.9 million (UK £1.85 million) grant from the U.K.’s National Institute for Health Research to support a new nocturnal hemodialysis product. The grant will go towards the development of a new dialysis machine concept that is specifically designed for nocturnal use, Quanta said. With the funds, Quanta […]
Gauss Surgical raises $3.3 million
Gauss Surgical raised $3.3 million and is looking to raise $600,000 more in a new round of equity financing, according to an SEC filing. Gauss’ flagship product is the Triton fluid management system, which runs on Apple’s iPad and calculates blood loss in surgical sponges by merely photographing them, the Los Altos, Calif.-based company said. The […]
Corindus inks distro deal with RaySafe
Corindus Vascular Robotics (OTC:CVRS) said yesterday it signed a distribution agreement with Unfors RaySafe to offer RaySafe’s i2 radiation dose monitoring system with Corindus’ CorPath system. The partnership will allow cath lab physicians and staff to better monitor and protect themselves from excessive radiation exposure, Waltham, Mass.-based Corindus said. “As more studies emerge, the push for improved […]